Frits Rosendaal
Frits Rosendaal
hoogleraar Klinische Epidemiologie, Leiden University Medical Center
Verified email at lumc.nl
Title
Cited by
Cited by
Year
Executive summary: heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
Circulation 129 (3), 399-410, 2014
20872*2014
Heart disease and stroke statistics—2017 update
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
8928*2017
Mutation in blood coagulation factor V associated with resistance to activated protein C
RM Bertina, BPC Koeleman, T Koster, FR Rosendaal, RJ Dirven, ...
Nature 369 (6475), 64-67, 1994
50251994
A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
SR Poort, FR Rosendaal, PH Reitsma, RM Bertina
38421996
American heart association statistics committee and stroke statistics subcommittee
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
Heart disease and stroke statistics-2017 update: a report from the American…, 2017
2518*2017
Heart disease and stroke statistics: 2006 update
American Heart Association
http://circ. ahajournals. org/cgi/reprint/CIRCULATIONAHA. 105.171600 v1, 2006
20392006
Venous thrombosis: a multicausal disease
FR Rosendaal
The Lancet 353 (9159), 1167-1173, 1999
19541999
Malignancies, prothrombotic mutations, and the risk of venous thrombosis
JW Blom, CJM Doggen, S Osanto, FR Rosendaal
Jama 293 (6), 715-722, 2005
19152005
A method to determine the optimal intensity of oral anticoagulant therapy
FR Rosendaal, SC Cannegieter, FJM Van der Meer, E Briet
Thrombosis and haemostasis 70 (03), 236-239, 1993
18391993
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
H Schunkert, IR Knig, S Kathiresan, MP Reilly, TL Assimes, H Holm, ...
Nature genetics 43 (4), 333-338, 2011
16712011
Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
T Koster, JP Vandenbroucke, FR Rosendaal, H de Ronde, E Brit, ...
The Lancet 342 (8886-8887), 1503-1506, 1993
16351993
Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
M Den Heijer, T Koster, HJ Blom, GMJ Bos, E Brit, PH Reitsma, ...
New England journal of medicine 334 (12), 759-762, 1996
13671996
Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
JP Vandenbroucke, T Koster, FR Rosendaal, E Brit, PH Reitsma, ...
The Lancet 344 (8935), 1453-1457, 1994
13641994
The risk of myocardial infarction associated with antihypertensive drug therapies
BM Psaty, SR Heckbert, TD Koepsell, DS Siscovick, TE Raghunathan, ...
Jama 274 (8), 620-625, 1995
13361995
Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis
T Koster, JP Vandenbroucke, FR Rosendaal, E Brit, AD Blann
The Lancet 345 (8943), 152-155, 1995
13281995
High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)[see comments]
FR Rosendaal, T Koster, JP Vandenbroucke, PH Reitsma
12991995
Incidence and mortality of venous thrombosis: a population‐based study
IA Nss, SC Christiansen, P Romundstad, SC Cannegieter, ...
Journal of thrombosis and haemostasis 5 (4), 692-699, 2007
12392007
Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials
Homocysteine Lowering Trialists' Collaboration
Bmj 316 (7135), 894-898, 1998
1229*1998
Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.
SC Cannegieter, FR Rosendaal, E Briet
Circulation 89 (2), 635-641, 1994
11821994
Optimal oral anticoagulant therapy in patients with mechanical heart valves
SC Cannegieter, FR Rosendaal, AR Wintzen, FJM Van der Meer, ...
New England Journal of Medicine 333 (1), 11-17, 1995
11561995
The system can't perform the operation now. Try again later.
Articles 1–20